Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped The study was halted after a Phase 3 study of dimebon failed to show efficacy.

Conditions

Alzheimer's Disease

Interventions

DRUG: dimebon

Sponsor

Medivation, Inc.